22157.jpg
Artificial Intelligence in Oncology Market Report 2022: Lower Rates of Diagnostic & Treatment Errors Brought By AI Boosts Adoption
October 07, 2022 08:43 ET | Research and Markets
Dublin, Oct. 07, 2022 (GLOBE NEWSWIRE) -- The "Artificial Intelligence in Oncology Market: Distribution by Type of Cancer, Type of End-Users and Key Geographical Regions: Industry Trends and Global...
arvinas_logoART_lg.jpg
Arvinas Appoints Paul McInulty as Senior Vice President, Regulatory Affairs
October 03, 2022 07:00 ET | Arvinas Inc.
NEW HAVEN, Conn., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
arvinas_logoART_lg.jpg
Arvinas Gives Back to Local Greater New Haven Community
September 30, 2022 09:00 ET | Arvinas Inc.
NEW HAVEN, Conn., Sept. 30, 2022 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
$10.8 Billion Worldwide Radiation Oncology Industry to 2027 - Featuring Accuray, Canon, Elekta and Hitachi Among Others
September 28, 2022 04:18 ET | Research and Markets
Dublin, Sept. 28, 2022 (GLOBE NEWSWIRE) -- The "Radiation Oncology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
arvinas_logoART_lg.jpg
Arvinas to Present at Bank of America Securities Precision Oncology Conference
September 26, 2022 07:00 ET | Arvinas Inc.
NEW HAVEN, Conn., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
CLS-LOGO-New2021.jpg
CLS Americas & Focalyx Present Integrated Fusion-Guided Focal Laser Ablation Solution at FOCAL 2022 Conference
September 23, 2022 07:00 ET | Clinical Laserthermia Systems Americas, Inc.
LOS ANGELES, Sept. 23, 2022 (GLOBE NEWSWIRE) -- CLS Americas, a subsidiary of Clinical Laserthermia Systems AB, and Focalyx Technologies, developer of image-guided fusion target devices, today...
arvinas_logoART_lg.jpg
Arvinas to Present at Upcoming Investor Conferences
August 31, 2022 07:00 ET | Arvinas Inc.
NEW HAVEN, Conn., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
MDxHealth Reports Half Year 2022 Results
August 25, 2022 16:00 ET | mdxhealth
NEWS RELEASE - REGULATED INFORMATION25 AUGUST 2022, 4:00PM EDT, 22:00 CET MDxHealth Reports Half Year 2022 Results IRVINE, CA, and HERSTAL, BELGIUM – August 25, 2022 – MDxHealth SA...
MDxHealth communique ses résultats financiers pour le premier semestre 2022
August 25, 2022 16:00 ET | mdxhealth
COMMUNIQUÉ DE PRESSE – INFORMATIONS RÉGLEMENTÉES25 AOÛT 2022, 16 h 00 EDT, 22 h 00 CET MDxHealth communique ses résultats financiers pour le premier semestre 2022 IRVINE, CA, et HERSTAL, BELGIQUE –...
arvinas_logoART_lg.jpg
Arvinas Announces Changes to its Board of Directors
August 18, 2022 16:01 ET | Arvinas Inc.
NEW HAVEN, Conn., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...